LifeMatrix has been awarded with a Start-up Innovation Project from Innosuisse, the Swiss Innovation Agency.

LifeMatrix Technologies has been awarded as the top cardiovascular medtech startup of 2023 by Med Tech Outlook.

The Pionierpreis is considered one of the most important innovation prizes in Switzerland and a significant award for young companies.

Our CEO, Maximilian Emmert gives an interview in the EACTS News about his experience winning the Techno Collage Innovation Award.

LifeMatrix wins CHF 150,000 to develop groundbreaking biomimetic implants designed to grow and regenerate with patients.

LifeMatrix under Global Game Changers in the annual report by Venture Kick.

LifeMatrix has been chosen by a jury of investors into the Swiss National Startup Team for Venture Leaders Life Sciences 2020 from over 60 applicants.

LifeMatrix wins VentureKicks financial support.

GlobalData: LifeMatrix set to disrupt cardiovascular implant market.

Tissue Engineering Will Disrupt Cardiovascular Implant Market.

Interview with Maximilian Emmert about the problems of transcatheter aortic valve implantation and how LifeMatrix could be the solution. 

Three Million Euros Awarded to Two UZH Researchers.

Study uses simulations to predict cultured heart valve growth. 

Computer-designed customized regenerative heart valves.

Kindern sollen Herzklappen aus dem Labor helfen

Künstliche Herzklappe wächst mit dem Kind.

Mitwachsende Prothesen für Babyherzen.